1.中国中医科学院西苑医院,北京市海淀区西苑操场路1号,100091
2.云南金七制药有限公司
sunlinjuan888@163.com
收稿:2022-06-16,
修回:2022-09-20,
纸质出版:2022-12-17
移动端阅览
陈文洁,何春颖,陈芷妍等.七叶神安滴丸治疗失眠症气虚证的随机、双盲、平行对照、多中心临床研究[J].中医杂志,2022,63(24):2339-2345.
CHEN Wenjie,HE Chunying,CHEN Zhiyan,et al.Insomnia with Qi Deficiency Syndrome group Treated with Qiye Shen'an Drop Pill (七叶神安滴丸):A Randomized, Double-blind, Parallel-Controlled, Multicenter Clinical Trial[J].Journal of Traditional Chinese Medicine,2022,63(24):2339-2345.
陈文洁,何春颖,陈芷妍等.七叶神安滴丸治疗失眠症气虚证的随机、双盲、平行对照、多中心临床研究[J].中医杂志,2022,63(24):2339-2345. DOI: 10.13288/j.11-2166/r.2022.24.008.
CHEN Wenjie,HE Chunying,CHEN Zhiyan,et al.Insomnia with Qi Deficiency Syndrome group Treated with Qiye Shen'an Drop Pill (七叶神安滴丸):A Randomized, Double-blind, Parallel-Controlled, Multicenter Clinical Trial[J].Journal of Traditional Chinese Medicine,2022,63(24):2339-2345. DOI: 10.13288/j.11-2166/r.2022.24.008.
目的
2
探讨七叶神安滴丸干预失眠症气虚证的有效性及安全性。
方法
2
采用多中心、随机、双盲、平行对照试验方法,收集9家医院失眠症气虚证患者288例,按照3∶1比例随机分为治疗组216例,对照组72例。两组均给予基础治疗。治疗组再给予七叶神安滴丸,对照组再给予七叶神安滴丸模拟剂,两组均每日3次,每次300 mg,饭后口服,疗程4周。治疗前后采用匹兹堡睡眠质量量表(PSQI)评价睡眠质量,疲劳严重度量表(FSS)评价疲劳程度;记录实验期间不良事件发生情况评价安全性;治疗后判定临床疗效。结果有效性评价分析采用全分析(FAS)集及符合方案(PPS)集分析;安全性指标以安全性(SS)集进行分析。
结果
2
288例患者均进入SS集,284例均进入FAS集(治疗组212例,对照组72例),247例进入PPS集(治疗组185例,对照组62例)。FAS集:治疗组临床总有效率(76.89%)明显高于对照组(27.78%)(
P
<0.0001);PPS集:治疗组临床总有效率(84.86%)明显高于对照组(30.65%)(
P
<0.0001)。PPS集与FAS集结果均显示,两组患者治疗后PSQI评分及FSS评分均较本组治疗前下降(
P
<0.0001),且治疗后治疗组较对照组明显降低(
P
<0.0001);治疗组PSQI评分及FSS评分治疗前后差值较对照组明显增加(
P
<0.0001)。治疗组不良事件发生率为6.94%(15/216),对照组为4.17%(3/72),均与试验无相关性。
结论
2
七叶神安滴丸治疗失眠症气虚证疗效较好,安全性较高。
Objective
2
To investigate the efficacy and safety of
Qiye Shen'an Drop Pill
(七叶神安滴丸) in the treatment of insomnia with
qi
deficiency syndrome.
Methods
2
A multicenter randomized double-blind parallel trial was designed to include 288 insomnia subjects with
qi
deficiency syndrome from 9 hospitals. The subjects were randomly allocated into intervention group (216 cases) and control group (72 cases) at a ratio of 3∶1. Routine treatment was given to all the subjects. Besides, the intervention group was orally administered with
Qiye Shen'an Drop Pill,
while the control group was given the corresponding placebo, both for 300mg each time, taken after meals, three times a day, four weeks totally. Pittsburgh Sleep Quality Inventory (PSQI) and Fatigue Severity Scale (FSS) were used to evaluate the sleep quality and fatigue severity before and after treatment, respectively. The occurrence of adverse events were recorded to evaluate the safety. The clinical effect was judged after treatment. Full analysis set (FAS) and per protocol set (PPS) were used for effectiveness analysis, while safety set (SS) was used for safety analysis.
Results
2
All 288 subjects were included in the SS, and there were 284 subjects in the FAS (212 in the intervention group and 72 in the control group), and 247 subjects in the PPS (185 in the intervention group and 62 in the control group). FAS analysis: the total clinical effective rate in the intervention group was 76.89%, significantly higher than 27.78% in the control group (
P
<0.0001). PPS analysis: the total effective rate in the intervention group (84.86%) was significantly higher than that in the control group (30.65%) (
P
<0.0001). PPS and FAS analyses both showed that PSQI and FSS scores significantly decreased after treatment (
P
<0.0001), and more decreases were found in the intervention group than in the control group (
P
<0.0001); and the differences of PSQI scores and FSS scores were significantly higher in the intervention group than those in the control group (
P
<0.0001). The incidence of adverse events was 6.94% in the intervention group (15/216) and 4.17% in the control group (3/72). All adverse events were judged to be not relevant to the trial.
Conclusion
2
Qiye Shen'an Drop Pill
has high efficacy and safety in treating insomnia with
qi
deficiency syndrome.
失眠定义、诊断及药物治疗共识专家组 . 失眠定义、诊断及药物治疗专家共识(草案) [J]. 中华神经科杂志 , 2006 , 39 ( 2 ): 141 - 143 .
MORIN CM , BENCA R . Chronic insomnia [J]. Lancet , 2012 , 379 ( 9821 ): 1129 - 1141 .
中国中医科学院失眠症中医临床实践指南课题组 . 失眠症中医临床实践指南(WHO/WPO) [J]. 世界睡眠医学杂志 , 2016 , 3 ( 1 ): 8 - 25 .
朱雪琦 , 付清楠 , 张捷 , 等 . 柴胡桂枝干姜汤合酸枣仁汤加减方治疗原发性失眠的随机对照临床研究 [J]. 北京中医药 , 2022 , 41 ( 7 ): 781 - 785 .
陈晓燕 , 蔡治国 , 王康锋 . 黄连温胆汤加减治疗痰热内扰型失眠临床观察 [J]. 世界睡眠医学杂志 , 2020 , 7 ( 12 ): 2064 - 2065 .
姜华 . 小剂量多塞平片结合七叶神安滴丸治疗失眠伴焦虑的疗效探究 [J]. 中国医药指南 , 2018 , 16 ( 7 ): 100 - 101 .
杨晓艳 . 小剂量多塞平片联合七叶神安滴丸治疗失眠伴焦虑疗效观察 [J]. 中医临床研究 , 2015 , 7 ( 7 ): 12 - 13 .
世界卫生组织 . ICD-10精神与行为障碍分类 [M].范肖冬,汪卫东,于欣,等译. 北京 : 人民卫生出版社 , 1993 : 144 - 145 .
国家中医药管理局不寐协作组 . 不寐(非器质性失眠症)中医诊疗方案(试行) [J]. 世界睡眠医学杂志 , 2015 , 2 ( 1 ): 14 - 18 .
BUYSSE DJ , REYNOLDS CF 3 RD, MONK TH, et al. The pittsburgh sleep quality index: a new instrument for psychiatric practice and research[J]. Psychiatry Res ,1989, 28 ( 2 ): 193 - 213 .
汤毓华 , 张明园 . 汉密顿抑郁量表(HAMD) [J]. 上海精神医学 , 1984 ( 2 ): 61 - 64 .
汤毓华 , 张明园 . 汉密顿焦虑量表(HAMA) [J]. 上海精神医学 , 1984 ( 2 ): 64 - 65 .
陈秀娟 , 王淑雅 , 吴桓宇 , 等 . 中药治疗失眠安慰剂效应的Meta分析 [J]. 世界中西医结合杂志 , 2017 , 12 ( 3 ): 313 - 317 .
方积乾 . 卫生统计学 [M]. 7版 . 北京 : 人民卫生出版社 , 2012 : 325 - 326 .
KRUPP LB , LAROCCA NG , MUIR-NASH J , et al . The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus .[J] Arch Neurol , 1989 , 46 ( 10 ): 1121 - 1123 .
杜文民 , 王永铭 , 程能能 . 药品不良反应的判定与其研究方法(续完) [J]. 中国药物警戒 , 2005 , 2 ( 1 ): 11 - 13,28 .
王继辉 , 魏钦令 , 梁文靖 . 原发性失眠症患者日间疲劳症状和过度觉醒的关系 [J]. 中华医学杂志 , 2015 , 95 ( 29 ): 2355 - 2358 .
张晶文 , 刘玲 . 从气虚论治失眠症 [J]. 湖北民族学院学报(医学版) , 2018 , 35 ( 2 ), 79 - 80,83 .
李时珍 . 本草纲目(校点本第二册) [M]. 北京 : 人民卫生出版社 , 1977 : 110 - 112 .
XIANG H , LIU Y , ZHANG B , et al . The antidepressant effects and mechanism of action of total saponins from the caudexes and leaves of Panax notoginseng in animal mo-dels of depression [J]. Phytomedicine , 2011 , 18 ( 8-9 ): 731 - 738 .
刘红 , 杨劲 , 唐向东 . 原发性失眠主客观睡眠质量与日间功能损害的关系 [J]. 华西医学 , 2013 , 28 ( 2 ): 209 - 213 .
潘胜珂 , 李惠 , 魏燕燕 , 等 . 安慰剂治疗原发性失眠症患者的meta分析 [J]. 上海交通大学学报(医学版) , 2020 , 40 ( 4 ): 505 - 513 .
0
浏览量
3
下载量
5
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010102007558号